on certain circumstances under which a pharmacist may decline to fill a prescription. Chapter 3—Safe Disposal of Unused Medication Sec. 3221. Short title. Sec. 3222. Disposal of controlled substances of a hospice patient by employees of a qualified hospice program. Sec. 3223. GAO study and report on hospice safe drug management. Chapter 4—Special Registration for Telemedicine Clarification Sec. 3231. Short title. Sec. 3232. Regulations relating to a special registration for telemedicine. Chapter 5—Synthetic Abuse and Labeling of Toxic Substances Sec. 3241. Controlled substance analogues. Chapter 6—Access to Increased Drug Disposal Sec. 3251. Short title. Sec. 3252. Definitions. Sec. 3253. Authority to make grants. Sec. 3254. Application. Sec. 3255. Use of grant funds. Sec. 3256. Eligibility for grant. Sec. 3257. Duration of grants. Sec. 3258. Accountability and oversight. Sec. 3259. Duration of program. Sec. 3260. Authorization of appropriations. Chapter 7—Using Data To Prevent Opioid Diversion Sec. 3271. Short title. Sec. 3272. Purpose. Sec. 3273. Amendments. Sec. 3274. Report. Chapter 8—Opioid Quota Reform Sec. 3281. Short title. Sec. 3282. Strengthening considerations for DEA opioid quotas. Chapter 9—Preventing Drug Diversion Sec. 3291. Short title. Sec. 3292. Improvements to prevent drug diversion. Title IV—Offsets Sec. 4001. Promoting value in Medicaid managed care. Sec. 4002. Requiring reporting by group health plans of prescription drug coverage information for purposes of identifying primary payer situations under the Medicare program. Sec. 4003. Additional religious exemption from health coverage responsibility requirement. Sec. 4004. Modernizing the reporting of biological and biosimilar products. Title V—Other Medicaid Provisions Subtitle A—Mandatory reporting with respect to adult behavioral health measures Sec. 5001. Mandatory reporting with respect to adult behavioral health measures. Subtitle B—Medicaid IMD Additional Info Sec. 5011. Short title. Sec. 5012. MACPAC exploratory study and report on